Filing Details

Accession Number:
0001179110-12-016897
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-12-04 19:16:42
Reporting Period:
2012-12-03
Filing Date:
2012-12-04
Accepted Time:
2012-12-04 19:16:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1158223 Affymax Inc AFFY Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1477384 A John Orwin C/O Affymax, Inc.
4001 Miranda Ave.
Palo Alto CA 94304
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-12-03 3,300 $5.83 95,300 No 4 M Direct
Common Stock Acquisiton 2012-12-03 12,498 $6.90 107,798 No 4 M Direct
Common Stock Disposition 2012-12-03 15,798 $24.22 92,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2012-12-03 12,498 $0.00 12,498 $6.90
Common Stock Stock Option (Right to Buy) Disposition 2012-12-03 3,300 $0.00 3,300 $5.83
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
162,513 2021-01-31 No 4 M Direct
38,900 2020-09-21 No 4 M Direct
Footnotes
  1. The shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. The shares vest and become exercisable in a series of forty-eight (48) successive equal monthly installments over the four (4) year period measured from February 1, 2011.
  3. The shares vest and become exercisable in a series of forty-eight (48) successive equal monthly installments over the four (4) year period measured from September 22, 2010.